A comparative evaluation for anxiolytic activity of Medhya Rasayana Ghrita administered by Nasya (Nasal route) versus Shamana Snehpana (oral administration) on occupational stress.

Datta Meghe Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1. Subjects who are willing to give written informed consent.
•2. Serum cortisol level > 15 mcg/dl, OSI score. ( 128-230.DownloadsOSI SCALE.pdf)
•3.Subjects of either gender between 25 to 40 years
•4.Subjects who are fit (yogya) for Nasya Karma & Shamana Snehapana
•5 Subjects of Madhyam Koshta,Madhyam Agnibala (samagni) will be included.

•1.Participants having ages less than 25 and more than 40 years of age of either sex.2. Person suffering from other psychiatric illnesses and using other anti-psychiatric medication 3..Patient suffering from any systemic chronic illness e.g., Asthma, COPD, Anemia, hepatic dysfunction, renal dysfunction, and Resistant hypertension, etc.4.Participants with a history of alcoholism and drug abuse.5. Pregnant, breastfeeding, or planning to become pregnant during the study.6. Peri-menopausal women. Patients having Nasal obstructive Pathology like congestion, Deviated Nasal septum, Nasal polyps etc . 7.Patients contraindicated for Nasya according to classics.. 8.Patients contraindicated for Shamana Snehapana

发起方